Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yardena Samuels

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2013
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanomaJared J Gartner, Stephen C J Parker, Todd D Prickett, et al.
Cancer Discovery|December 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cancer Discovery|October 7, 2025
Recurrent immunogenic neoantigens and their cognate T-cell receptors in treatment-resistant metastatic prostate cancerNofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Cancer Discovery|January 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in MelanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cancer Cell|March 28, 2025
Translation dysregulation in cancer as a source for targetable antigensChen Weller, Osnat Bartok, Christopher S McGinnis, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2013
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanomaJared J Gartner, Stephen C J Parker, Todd D Prickett, et al.
Cancer Discovery|December 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cancer Discovery|October 7, 2025
Recurrent immunogenic neoantigens and their cognate T-cell receptors in treatment-resistant metastatic prostate cancerNofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Cancer Discovery|January 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in MelanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cancer Cell|March 28, 2025
Translation dysregulation in cancer as a source for targetable antigensChen Weller, Osnat Bartok, Christopher S McGinnis, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Pageof 11